Thursday, 24 May 2012

Food And Drug Administration-Acute Coronary Syndrome-New Blood Thinner-Healthday News

FDA Panel Votes Against New Use for Blood Thinner Xarelto

WEDNESDAY, May 23 (Healthday News) -- An advisory panel to the U.S. Food and Drug Administration on Wednesday voted against a new use of a new blood thinner, Xarelto, to cut the risk of potentially lethal clots in people with acute coronary syndrome. read more..

No comments:

Post a comment